½ÃÀ庸°í¼­
»óǰÄÚµå
1477289

¼¼°èÀÇ ½ÉÀå ÆÇ¸· Àý°³±â ½ÃÀå : À¯Çüº°, ¼ö±â À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°

Cardiac Valvulotome Market, By Type By Procedure Type By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÉÀå ÆÇ¸· Àý°³±â ½ÃÀåÀº 2024³â¿¡´Â 1¾ï 1,580¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í 2024-2031³âÀÇ CAGRÀº 4.5%¸¦ ³ªÅ¸³ÂÀ¸¸ç, 2031³â¿¡´Â 1¾ï 5,720¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁسâ 2023³â 2024³â ½ÃÀå ±Ô¸ð 1¾ï 1,580¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2019-2023³â ¿¹Ãø ±â°£ 2024-2031³â
¿¹Ãø±â°£ 2024-2031³â CAGR 4.50% 2031³â ±Ý¾× ¿¹Ãø 1¾ï 5,720¸¸ ´Þ·¯
±×¸². ½ÉÀåÆÇ Àý°³±â ½ÃÀå Á¡À¯À²(%), 2024³â Áö¿ªº°
Cardiac Valvulotome Market-IMG1

½ÉÀå ÆÇ¸· Àý°³±â´Â Á¼Àº ½ÉÀå ÆÇ¸·À» ±³Á¤ÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. °³½É¼ú ½Ã ÈäºÎ¸¦ ÀÛ°Ô Àý°³ÇÏ¿© »ðÀÔÇÏ´Â ¼ö¼ú±â±¸ÀÔ´Ï´Ù. ½ÉÀå ÆÇ¸· ¸µ Ȧ´õ´Â Á¼Àº ½ÉÀå ÆÇ¸·¸¦ ºÐÇÒÇϰí È®ÀåÇÏ´Â µ¥ »ç¿ëµÇ´Â °³Æó °¡´ÉÇÑ Àý´Ü ³¯À» Æ÷ÇÔÇÏ´Â Áß°ø »þÇÁÆ®·Î ±¸¼ºµË´Ï´Ù. ¹ëºê ÀÔÀ» È®´ëÇÏ¿© Á¤»óÀûÀÎ Ç÷·ù¸¦ ȸº¹½Ãų ¼ö ÀÖ½À´Ï´Ù. ½ÉÀå ÆÇ¸· ÇùÂøÁõÀº ½Ã°£ÀÌ Áö³²¿¡ µû¶ó ÆÇ¸·ÀÌ µÎ²®°í À¶ÇÕÇÏ¿© ÆÇ¸·ÀÇ ¿òÁ÷ÀÓÀÌ Á¦ÇѵǾî Ç÷¾×ÀÇ ±æÀ» Á¼È÷´Â °ÍÀ¸·Î ÀϾ´Ï´Ù. Ä¡·áÇÏÁö ¾Ê°í ¹æÄ¡ÇÏ¸é ÆóºÎÁ¾°ú ½ÉºÎÀü°ú °°Àº ½É°¢ÇÑ ÇÕº´ÁõÀ» ÀÏÀ¸Å³ ¼ö ÀÖ½À´Ï´Ù. ÆÇ¸·±â¸¦ ÀÌ¿ëÇÑ ½ÉÀå ÆÇ¸· Àý°³¼úÀº ´ëµ¿¸Æ ÆÇ¸·°ú ½Â¸ðÆÇÀÇ ÇùÂøÀ» ±³Á¤Çϴ ǥÁØ ¼ö¼ú ¹æ¹ýÀÔ´Ï´Ù. ¸âºê·¹ÀÎÀº µÎ²¨¿î ¹ëºê Á¶Á÷À» ¿­°í ¹ëºê ÀÔ±¸¸¦ Á¤»ó Å©±â·Î µÇµ¹¸³´Ï´Ù. ÀÌ ³·Àº ħ½ÀÀû ÀýÂ÷´Â ½É°¢ÇÑ ÆÇ¸· ÇùÂø ȯÀÚÀÇ Ä¡·á ¼ºÀûÀ» Å©°Ô Çâ»ó ½ÃÄ×½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°èÀÇ ½ÉÀå ÆÇ¸· Àý°³±â ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ´Â °ÍÀº ³ëÈ­¿¡ µû¸¥ ÆÇ¸·Áõ¿¡ °É¸®±â ½¬¿î ³ëÀÎ Àα¸ Áõ°¡ÀÔ´Ï´Ù. WHO¿¡ µû¸£¸é 65¼¼ ÀÌ»óÀÇ Àα¸´Â 2050³â±îÁö 15¾ï ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, °³¹ßµµ»ó±¹¿¡¼­ ·ù¸¶Æ¼½º¼º ½ÉÀå ÁúȯÀÇ À¯º´·ü Áõ°¡µµ ½ÉÀå ÆÇ¸·Áõ Ä¡·áÀÇ Çʿ伺À» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ħ½À¼ºÀÌ ³·Àº Ä¡·á¹ýÀ» Á¦°øÇÏ´Â »õ·Î¿î °æ Ä«Å×ÅÍ ¹ëºê ´ëü ±â¼ú ½ÃÀå °³Ã´Àº ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦ÇÒ ¼ö ÀÖ½À´Ï´Ù. dz¼± ÆÇ¸· ¼ºÇü¼ú°ú °°Àº ´ëü ÀýÂ÷´Â ÀüÅëÀûÀÎ ½ÉÀå ÆÇ¸· Àý°³¼ú¿¡ ¾ö°ÝÇÑ °æÀïÀ» ÃÊ·¡ÇÕ´Ï´Ù. ±×·³¿¡µµ ºÒ±¸ÇÏ°í ½ÉÀå ÆÇ¸· Àý°³±â´Â °æµµ¿¡¼­ Áߵ ÆÇ¸· ÇùÂøÀÇ ±³Á¤¿¡ ¿©ÀüÈ÷ À¯¿ëÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº ½ÅÈï±¹¿¡¼­ÀÇ ÀÇ·á ÁöÃâ Áõ°¡¿Í ½ÉÀå Ä¡·áÀÇ ¿ëÀ̼ºÀ¸·ÎºÎÅÍ ºñÁî´Ï½º ±âȸ¸¦ ¹ß°ßÇϰí ÀÖ½À´Ï´Ù.

ÀÌ Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ÀÌ Á¶»ç º¸°í¼­´Â ¼¼°è ½ÉÀå ÆÇ¸· Àý°³±â ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®Çϰí 2023³âÀ» ±âÁسâÀ¸·Î ÇÑ ¿¹Ãø±â°£(2024-2031³â) ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)¿Í º¹ÇÕ¿¬°£ ¼ºÀå·ü(CAGR%) ¸¦ °Ô½ÃÇÕ´Ï´Ù.
  • ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ »ó½Ã¿Í ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.
  • ¿£ÅÍÇÁ¶óÀÌÁî ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ½ÇÀû, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ½ÉÀåÆÇ Àý°³±â ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­¸¦ ÅëÇØ ÅëÂû·ÂÀº ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀÌ ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù.
  • ½ÉÀå ÆÇ¸· Àý°³±â ¼¼°è ½ÃÀåÀº ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ¼ö¿ëÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ½ÉÀåÆÇ Àý°³±â ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç °áÁ¤ÀÌ ¿ëÀÌÇØÁý´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • ÀϰüÇü ±âȸ ¸Ê(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • Á¦Ç° Ãâ½Ã/½ÂÀÎ
  • ÀÚ±Ý Á¶´Þ ¹× ÅõÀÚ
  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ½ÉÀåÆÇ Àý°³±â ½ÃÀå-Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎÀÇ ´ëó
  • ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ½ÉÀå ÆÇ¸· Àý°³±â ½ÃÀå, À¯Çüº°(2019-2031³â)(100¸¸ ´Þ·¯)

  • ¼Ò°³
  • È®Àå ½ÉÀå ÆÇ¸· Àý°³±â
  • ¿ÍÀÌ¾î ½ÉÀå ÆÇ¸· Àý°³±â

Á¦6Àå ¼¼°èÀÇ ½ÉÀåÆÇ Àý°³±â ½ÃÀå, ¼ö¼ú À¯Çüº°(2019-2031³â)(100¸¸ ´Þ·¯)

  • ¼Ò°³
  • ÆÇ¸·Àý°³¼ú
  • ½Â¸ðÆÇ Àý°³¼ú
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ½ÉÀå ÆÇ¸· Àý°³±â ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº°(2019-2031³â)(100¸¸ ´Þ·¯)

  • ¼Ò°³
  • º´¿ø
  • ½ÉÀå ¿Ü°ú ¼¾ÅÍ
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ½ÉÀåÆÇ Àý°³±â ½ÃÀå, Áö¿ªº°(2019-2031³â)(100¸¸ ´Þ·¯)

  • ¼Ò°³
  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¿µ±¹
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ÇÁ¶û½º
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • Àεµ
  • ÀϺ»
  • ASEAN ±¹°¡
  • È£ÁÖ
  • Çѱ¹
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • °ÉÇÁ Çù·Â ȸÀÇ
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ºÏ¾ÆÇÁ¸®Ä«
  • Áß¾Ó ¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • LeMaitre
    • INVAMED
    • GeoSurgical
    • LimFlow, Inc.
    • B. Braun SE
    • Teleflex Incorporated
    • StarFish Product Engineering Inc.
    • Koven Technology Canada Inc.
    • Andramed
    • Zgrum Medical
    • BD
    • PEAK SURGICAL
    • Symmetry Surgical Inc.

Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ ½ÃÁ¡

  • À¶¼º°ú ¼èÅð
  • ÀϰüÇü ±âȸ ¸Ê

Á¦11Àå Âü°í¹®Çå°ú Á¶»ç¹æ¹ý

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
JHS 24.05.21

The cardiac valvulotome market is estimated to be valued at USD 115.8 Mn in 2024 and is expected to reach USD 157.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.5% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 115.8 Mn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 4.50% 2031 Value Projection: US$ 157.2 Mn
Figure. Cardiac Valvulotome Market Share (%), By Region 2024
Cardiac Valvulotome Market - IMG1

Cardiac valvulotome is a medical device used in the correction of stenotic cardiac valves. It is a surgical tool inserted through small incisions made in the chest during open-heart surgery. The cardiac valvulotome consists of hollow shafts containing retractable cutting blades that are used to split and dilate narrowed heart valves. It helps restore normal blood flow by enlarging the valve opening. Cardiac valvular stenosis occurs due to the thickening and fusion of valve leaflets over time, restricting their movement and narrowing the passage of blood. Left untreated, it can lead to serious complications like pulmonary edema or heart failure. Cardiac valvulotomy employing a valvulotome is a standard surgical procedure to correct stenosis of the aortic and mitral valves. The valvulotome cuts through the thickened valve tissue, restoring the opening to its normal size. This minimally invasive technique has significantly improved outcomes for patients with severe valve narrowing.

Market Dynamics:

The global cardiac valvulotome market growth is driven by the rising geriatric population who are more prone to age-related valvular diseases. According to the WHO, the number of people aged 65 years and above is projected to reach 1.5 billion by 2050. Furthermore, growing prevalence of rheumatic heart disease in developing nations is also prompting the need for cardiac valvulotome procedures. However, the market growth can be restrained by the development of novel transcatheter valve replacement technologies that provide less invasive treatment options. Alternative procedures like balloon valvuloplasty present stiff competition to traditional cardiac valvulotomy. Nevertheless, valvulotomes continue to remain helpful for correcting mild to moderate valve stenosis. The market sees opportunities from increasing healthcare expenditure and accessibility of cardiac treatments in emerging economies.

Key Features of the Study:

  • This report provides in-depth analysis of the global cardiac valvulotome market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global cardiac valvulotome market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes LeMaitre, INVAMED, GeoSurgical, LimFlow, Inc., B. Braun SE, Teleflex Incorporated, StarFish Product Engineering Inc., Koven Technology Canada Inc., Andramed, Zgrum Medical, BD, PEAK SURGICAL, and Symmetry Surgical Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global cardiac valvulotome market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac valvulotome market.

Detailed Segmentation-

  • Type:
    • Expandable Cardiac Valvulotome
    • Over the Wire Cardiac Valvulotome
  • Procedure Type:
    • Valvulotomy
    • Mitral Valve Commissurotomy
    • Others
  • End User:
    • Hospitals
    • Cardiac Surgery Centers
    • Ambulatory Surgical Centers
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • LeMaitre
    • INVAMED
    • GeoSurgical
    • LimFlow, Inc.
    • Braun SE
    • Teleflex Incorporated
    • StarFish Product Engineering Inc.
    • Koven Technology Canada Inc.
    • Andramed
    • Zgrum Medical
    • BD
    • PEAK SURGICAL
    • Symmetry Surgical Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Procedure Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Fundings and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Cardiac Valvulotome Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the market

5. Global Cardiac Valvulotome Market, By Type, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Expandable Cardiac Valvulotome
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Over the Wire Cardiac Valvulotome
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Cardiac Valvulotome Market, By Procedure Type, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Valvulotomy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Mitral Valve Commissurotomy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Cardiac Valvulotome Market, By End User, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Cardiac Surgery Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Ambulatory Surgical Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Cardiac Valvulotome Market, By Region, 2019 - 2031, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Regions, 2019-2031
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profiles
    • LeMaitre
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • INVAMED
    • GeoSurgical
    • LimFlow, Inc.
    • B. Braun SE
    • Teleflex Incorporated
    • StarFish Product Engineering Inc.
    • Koven Technology Canada Inc.
    • Andramed
    • Zgrum Medical
    • BD
    • PEAK SURGICAL
    • Symmetry Surgical Inc.

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦